CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Cranial and Auricular Electrostimulation (CES) — Coverage Criteria

Policy on coverage and medical necessity for cranial electrotherapy stimulation (CES) and electrical stimulation of auricular acupuncture points for BlueCHiP for Medicare and Commercial products; defines coverage stance and coding guidance.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyCranial and Auricular Electrostimulation (CES) — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateMar 7, 2017

Next Review DateN/A

Key ActionDo not bill for CES or auricular electrostimulation for BlueCHiP for Medicare or Commercial products as these services are not covered / not medically necessary.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Not coveredOverall coverage stance for CES and auricular electrostimulation

Unlisted codeCoding guidance

FDA 510(k)Regulatory status

LimitedEvidence base

Coverage Determinations

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Not medically necessary / Not covered

Covered when ALL of the following are met:

Primary coverage decision: Cranial electrotherapy stimulation (CES) is not covered / not medically necessary as evidence is insufficient to determine the effects of the technology on health outcomes.

Applies to BlueCHiP for Medicare and Commercial products as stated.

Auricular electrostimulation: Electrical stimulation of auricular acupuncture points is not covered / not medically necessary as evidence is insufficient to determine the effects of the technology on health outcomes.

Applies to BlueCHiP for Medicare and Commercial products as stated.

The following HCPCS codes are specifically identified as not covered / not medically necessary: S8930 (Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with patient) and K1002 (Cranial electrotherapy stimulation (CES) system, includes all supplies and accessories, any type; effective 1/1/2020).

If a service is determined to be not medically necessary or is a non-covered benefit, payment may be denied. Providers may not bill members for such services unless the member was informed in advance and agreed to pay out-of-pocket; refer to the member's subscriber agreement or employer agreement and your participation agreement for applicable provisions.

For Commercial products, cranial electrotherapy stimulation (CES) and electrical stimulation of auricular acupuncture points are considered not medically necessary because the evidence is insufficient to determine effects on health outcomes. The same insufficiency of evidence is noted for BlueCHiP for Medicare regarding electrical stimulation of auricular acupuncture.

This excerpt does not provide specific clinical criteria that define when a service is considered not medically necessary; it emphasizes administrative consequences (denial of payment) and directs providers to verify member-specific benefits and participation agreements for guidance.

Provider Responsibilities and Billing Actions

Prior Authorization

Prior authorization is not applicable for these services.

Note

Check Member-Specific Requirements

Providers must check member-specific benefits and participation before delivering services. Benefit coverage is determined by the member's subscriber agreement, member certificate, or employer agreement and may supersede this policy.

Call the provider call center for member-specific eligibility and benefit information.
Refer to the member's subscriber agreement / certificate for applicable benefits and limitations.

Denial Risk

Denial and Member Billing Risk

Services for cranial electrotherapy stimulation (CES) and electrical stimulation of auricular acupuncture points are not covered/not medically necessary. If services are determined to be not covered or not medically necessary for a member, providers may not bill the member unless the member was informed in advance and agreed in writing to accept financial responsibility.

Non-covered or medically unnecessary services may be denied.
Providers must follow participation agreement requirements regarding member notification and consent before billing members.

Billing Rule

Coding and Reporting Note

There is no specific CPT or HCPCS code for cranial electrotherapy stimulation; report the service using an appropriate unlisted procedure code. The following HCPCS codes are identified as not covered/not medically necessary:

S8930 — Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with patient (not covered / not medically necessary).
K1002 — Cranial electrotherapy stimulation (CES) system, includes all supplies and accessories, any type (Effective 1/1/2020) (not covered / not medically necessary).
Report CES with an unlisted procedure code when applicable.

Note

Member Benefits and Eligibility

For member-specific benefits or questions about eligibility, contact the provider call center. The member's subscriber agreement or employer agreement governs coverage determinations.

Contact the provider call center for eligibility and benefit confirmation.
Coverage decisions are based on the member's subscriber agreement/certificate and may override this policy.

Clinical Background and Evidence Summary

Cranial electrotherapy stimulation (CES) delivers a low‑intensity pulsed electrical current to sites such as the earlobes, mastoid processes, or scalp using devices (for example, Alpha‑Stim). Devices that target auricular acupuncture points (for example, the P‑Stim) provide electrical stimulation to specific ear points. These modalities have been evaluated in small sham‑controlled trials and case series for conditions including anxiety, depression, chronic pain, insomnia, and opioid withdrawal, but the evidence is heterogeneous and insufficient to establish clinical benefit.

Definitions

CES and Auricular electrostimulation — definitions and brief descriptions

Definition - Cranial electrotherapy stimulation (CES)Delivery of a weak electrical current to the earlobes, mastoid processes, or scalp using devices (e.g., Alpha‑Stim) to modulate brain networks; evaluated for pain, insomnia, depression, anxiety, and functional constipation.

Definition - Auricular electrostimulationElectrical stimulation of auricular acupuncture points on the ear using devices (e.g., P‑Stim, E‑pulse) that may provide ambulatory stimulation over days and target specific auricular points.

Typical devices & deliveryExamples include Alpha‑Stim (CES via clip electrodes on earlobes) and P‑Stim (single‑use auricular stimulator worn behind the ear, preprogrammed on/off cycles).

Proposed mechanismThought to modulate activity in brain networks (hypothalamus, limbic system, reticular activating system) through low‑intensity pulsed current.

Auricular electroacupuncture — referenced studies

Study types referencedAuricular electroacupuncture is reported in randomized and pilot studies, including trials for obesity, rheumatoid arthritis, and opioid detoxification.

Example RCTs/pilotsSchukro et al. (obesity pilot randomized placebo‑controlled), Bernateck et al. (auricular electroacupuncture in rheumatoid arthritis), Kroening & Oleson (narcotic detoxification cases).

Evidence characteristicsMultiple small randomized and pilot studies with heterogeneous interventions and conditions studied (weight loss, rheumatoid arthritis, opioid withdrawal).

Cranial electrotherapy stimulation (CES) — trials and reviews

Conditions evaluatedCES has been studied in trials and systematic reviews for anxiety, depression, chronic pain, and insomnia.

Key evidence sourcesClinical trial examples include Barclay & Barclay (anxiety with comorbid depression) and pilot/double‑blind studies for treatment‑resistant depression; systematic reviews assess benefits and harms for chronic painful conditions, depression, anxiety, and insomnia.

Evidence summaryThe literature consists of multiple small sham‑controlled trials and systematic reviews; protocols and results are heterogeneous across studies.